Results 81 to 90 of about 73,420 (103)

Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation

Phytomedicine, 2021
, Zhiping Lv, Yuqi Lai
exaly  

New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases

Cells, 2022
Nai-Hong Chen, Qidi Ai, Fan Yi
exaly  

Ginsenoside Rg1 Ameliorates Neuroinflammation via Suppression of Connexin43 Ubiquitination to Attenuate Depression

Frontiers in Pharmacology, 2021
Nai-Hong Chen, Songwei Yang, Siyu Ren
exaly  

Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington’s disease via suppressing MAPKs and NF-κB pathways in the striatum

Acta Pharmacologica Sinica, 2020
Nai-Hong Chen, Zhen-Zhen Wang, Yuhe Yuan   +2 more
exaly  

Antidepressant‐like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus

British Journal of Pharmacology, 2012
Bo Jiang
exaly  

Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization

Acta Pharmacologica Sinica, 2020
Zhao Zhang, Nai-Hong Chen
exaly  

Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC–MS/MS: Rg1 excretion in rat bile, urine and feces

Acta Pharmaceutica Sinica B, 2016
Nai-Hong Chen, Min Huang
exaly